Bristol-Myers Squibb Company BMY
62.14 USD -0.99 (-1.57%)
At closeNov 9, 2026, 5:09 AM EST
63.44 +1.30 +2.10%
Pre-market · Nov 9, 5:09 AM ET
61.33 Day range 63.06
45.27 52-week range 68.64
- YTD
- +15.20%
- 1 year
- +33.26%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 48.19B | 48.30B | 45.01B | 46.16B | 46.38B | |
| 34.26B | 34.33B | 34.31B | 36.02B | 36.45B | |
| 9.33B | -8.38B | 8.44B | 7.71B | 8.10B | |
| 7.05B | -8.95B | 8.03B | 6.33B | 6.99B | |
| 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.21B | 10.35B | 11.46B | 9.12B | 13.98B | |
| 90.04B | 92.60B | 95.16B | 96.82B | 109.31B | |
| 71.53B | 76.22B | 65.67B | 65.70B | 73.31B | |
| 45.11B | 49.65B | 39.77B | 39.32B | 44.55B | |
| 18.47B | 16.34B | 29.43B | 31.06B | 35.95B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 14.16B | 15.19B | 13.86B | 13.07B | 16.21B | |
| -4.13B | -21.35B | -2.29B | -1.06B | -538.00M | |
| -10.35B | 5.13B | -9.42B | -16.96B | -16.22B | |
| -1.31B | -1.25B | -1.21B | -1.12B | -973.00M | |
| -129.00M | -1.17B | 2.19B | -4.99B | -657.00M |